Form 8-K · Current Report · Filed 2025-04-24
IQVIA Holdings Inc. Approves Amendments to Charter and Director Elections at Annual Meeting
IQVIA Holdings Inc. held its 2025 Annual Meeting of Stockholders on April 24, 2025, where stockholders approved amendments to the company's Amended and Restated Certificate of Incorporation and elected new board members. The amendment provides for the exculpation from liability for certain officers to the fullest extent permitted by Delaware law and removes obsolete provisions. Nine nominees were elected to the board for one-year terms with majority votes. Financial Statements and exhibits were also filed as part of the 8-K.
- Filer
- Iqvia Holdings Inc. IQV · NYSE
- Filed
- Accession
- 0001193125-25-093687
- CIK
- 0001478242
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Amendments to Articles of Incorporation or Bylaws
Submission of Matters to a Vote of Security Holders
Financial Statements and Exhibits
Market reaction
Close before filing
$147.06
Next session
+2.2%
Since filing
+59.8%
Latest close
$235.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from IQV reporting the same item, with the next session's move:
Exhibits (1)
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Never miss another IQV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.